Glucose-6-phosphate dehydrogenase deficiency and intravascular haemolysis.
D000293:Adolescent; D000328:Adult; D000743:Anemia, Hemolytic / Q000139:chemically induced / Q000209:etiology*; D001241:Aspirin / Q000009:adverse effects; D003622:Dapsone / Q000009:adverse effects; D005260:Female; D005955:Glucosephosphate Dehydrogenase Deficiency / Q000150:complications*; D006456:Hemoglobinuria / Q000139:chemically induced / Q000209:etiology*; D006801:Humans; D008297:Male; D009281:Naphthalenes / Q000009:adverse effects; D009549:Nigeria; D011739:Pyrimethamine / Q000009:adverse effects; D014435:Typhoid Fever / Q000150:complications
D009281:Naphthalenes; D003622:Dapsone; D001241:Aspirin; D011739:Pyrimethamine